Business

A report from research firm Decision Resources predicts no growth in the asthma drug market through 2020, in large part due to incursions by generics and greater competition. According to the company, “The overall asthma… Read more . . .

Merck and NanoBio will conduct preclinical studies to evaluate a vaccine combining Merck’s respiratory syncyctial virus (RSV) antigen with NanoBio’s NanoStat adjuvant. NanoBio has already conducted studies that showed the induction of immunity by a… Read more . . .

Swedish pharma company Meda released a statement regarding a new patent for its Astepro nasal spray that reads in its entirety: “The United States Patent and Trademark Office (USPTO) today issued a patent related to… Read more . . .

Consort Medical, parent company of device developer and manufacturer Bespak, reports “strong volume growth” for Bespak’s inhaler business for the six months ending October 31, 2011. Bespak revenues were up 17% from 2010, with operating… Read more . . .

Acacia Research, a California company frequently described as a “patent troll,” says that it has acquired 13 patents for inhaler technology from “a major medical company.” Company CEO Paul Ryan said, “Acacia continues to increase… Read more . . .

AstraZeneca has asked the New Zealand High Court to review a decision by Pharmac, the government drug purchasing agency, to reduce its subsidy for the Symbicort Turbuhaler to achieve pricing parity with GSK’s Seretide (Advair)… Read more . . .

The Michael J. Fox Foundation (MJFF) for Parkinson’s Research (MJFF) has awarded a grant to Civitas Therapeutics to support development of the company’s lead product, CVT-301, an inhaled levodopa (L-dopa) formulation for the treatment of… Read more . . .

Tokyo-based Eisai will co-promote three Novartis inhaled COPD therapies in Japan with Novartis Pharma K.K. Starting on December 1, 2011, both companies will promote Onbrez indacaterol inhalation capsules, with Novartis targeting flagship and university hospitals… Read more . . .